FDA Aims To Tap Sentinel Data Network For Drug Effectiveness Studies
Executive Summary
New ‘Guardian’ program to monitor post-market effectiveness through the Sentinel electronic data network will take five years to build, FDA’s Woodcock says.
You may also be interested in...
Sentinel May Expand To Generic Equivalence Studies
Tool being designed for rapid queries of US Sentinel data to consider generic drug switches, potentially spot equivalence problems.
Sentinel May Expand To Generic Equivalence Studies
Tool being designed for rapid queries of US Sentinel data to consider generic drug switches, potentially spot equivalence problems.
PDUFA VI: FDA Proposes Expanding Sentinel, Real-World Safety Data Sources
Growth of post-market surveillance system also may require more resources.